OpenURL Connection Search

Select item for more details and to access through your institution.

Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.
Published in:
2016
By:
- Yardley, Denise A.;
- Reeves, James;
- Dees, E. Claire;
- Osborne, Cynthia;
- Paul, Devchand;
- Ademuyiwa, Foluso;
- Soliman, Hatem;
- Guthrie, Troy;
- Andersen, Jay;
- Krekow, Lea;
- Choksi, Janak;
- Daniel, Brooke;
- Danso, Michael;
- Favret, Anne;
- Oommen, Sanjay;
- Brufsky, Adam;
- Bromund, Jane L.;
- Yong Lin;
- Ibrahim, Ayman B.;
- Richards, Paul D.
Publication type:
journal article
Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial.
Published in:
Clinical Breast Cancer, 2011, v. 11, n. 2, p. 82, doi. 10.1016/j.clbc.2011.03.005
By:
- Robert, Nicholas J.;
- Saleh, Mansoor N.;
- Paul, Devchand;
- Generali, Daniele;
- Gressot, Laurent;
- Copur, Mehmet S.;
- Brufsky, Adam M.;
- Minton, Susan E.;
- Giguere, Jeffrey K.;
- Smith II, John W.;
- Richards, Paul D.;
- Gernhardt, Diana;
- Huang, Xin;
- Liau, Katherine F.;
- Kern, Kenneth A.;
- Davis, John
Publication type:
Article
ASO Visual Abstract: Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
Published in:
2022
By:
- Whitworth, Pat;
- Beitsch, Peter D.;
- Pellicane, James V.;
- Baron, Paul L.;
- Lee, Laura A.;
- Dul, Carrie L.;
- Nash III, Charles H.;
- Murray, Mary K.;
- Richards, Paul D.;
- Gittleman, Mark;
- Budway, Raye;
- Layeequr Rahman, Rakhshanda;
- Kelemen, Pond;
- Dooley, William C.;
- Rock, David T.;
- Cowan, Ken H.;
- Lesnikoski, Beth-Ann;
- Barone, Julie L.;
- Ashikari, Andrew Y.;
- Dupree, Beth
Publication type:
Abstract
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 7, p. 4141, doi. 10.1245/s10434-022-11666-2
By:
- Whitworth, Pat;
- Beitsch, Peter D.;
- Pellicane, James V.;
- Baron, Paul L.;
- Lee, Laura A.;
- Dul, Carrie L.;
- Nash III, Charles H.;
- Murray, Mary K.;
- Richards, Paul D.;
- Gittleman, Mark;
- Budway, Raye;
- Rahman, Rakhshanda Layeequr;
- Kelemen, Pond;
- Dooley, William C.;
- Rock, David T.;
- Cowan, Ken;
- Lesnikoski, Beth-Ann;
- Barone, Julie L.;
- Ashikari, Andrew Y.;
- Dupree, Beth
Publication type:
Article
The antiemetic efficacy of secobarbital and chlorpromazine compared to metoclopramide, diphenhydramine, and dexamethasone. A randomized trial.
Published in:
1986
By:
- Richards, Paul D.;
- Flaum, Morris A.;
- Bateman, Marilyn;
- Kardinal, Carl G.;
- Richards, P D;
- Flaum, M A;
- Bateman, M;
- Kardinal, C G
Publication type:
journal article

Found: 5

Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.

Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial.

ASO Visual Abstract: Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.

Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.

The antiemetic efficacy of secobarbital and chlorpromazine compared to metoclopramide, diphenhydramine, and dexamethasone. A randomized trial.